Back to Search
DAVID RABEN, MD
MD
Radiation Oncology Physician
NPI: 1982711727Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
37178(CO)
Research & Publications (20)
Vascular-targeting agents and radiation therapy in lung cancer: where do we stand in 2005?
PMID 16354311·Clin Lung Cancer·2005
6-review
The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
PMID 15701870·Clin Cancer Res·2005
4-observational
Angiogenesis inhibitors: a rational strategy for radiosensitization in the treatment of non-small-cell lung cancer?
PMID 15310417·Clin Lung Cancer·2004
6-review
Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?
PMID 15095260·Semin Radiat Oncol·2004
6-review
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
PMID 15299080·Mol Cancer Ther·2004
7-preclinical
Interference with EGFR signaling: paradigm for improving radiation response in cancer treatment.
PMID 12647989·Expert Rev Anticancer Ther·2002
6-review
Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
PMID 15142632·Int J Radiat Oncol Biol Phys·2004
6-review
Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not know.
PMID 12867058·Lung Cancer·2003
6-review
ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer.
PMID 11894012·Semin Oncol·2002
6-review
Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose- and sequence-dependent manner.
PMID 19220256·BJU Int·2009
8-other
Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy.
PMID 19307945·Am J Clin Oncol·2009
3-trial
Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
PMID 19362783·Int J Radiat Oncol Biol Phys·2009
8-other
Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach.
PMID 19168295·Int J Radiat Oncol Biol Phys·2009
8-other
Integrating biologically targeted therapy in head and neck squamous cell carcinomas.
PMID 19028346·Semin Radiat Oncol·2009
6-review
Select cyclopentenone prostaglandins trigger glutathione efflux and the role of ABCG2 transport.
PMID 19520157·Free Radic Biol Med·2009
8-other
Signaling at the membrane interface by the DGK/SK enzyme family.
PMID 19066401·J Lipid Res·2009
6-review
High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
PMID 18501097·Clin Lung Cancer·2008
8-other
Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial.
PMID 18525306·Am J Clin Oncol·2008
3-trial
Pharmacokinetic-directed dosing of vandetanib and docetaxel in a mouse model of human squamous cell carcinoma.
PMID 18790781·Mol Cancer Ther·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12605 E 16TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1982711727
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile